Modelling cost effectiveness of insulin glargine for the treatment of type 1 and 2 diabetes in Canada. Pharmacoeconomics. 2007;25(3):253-266.Grima DT, Thompson MF, Sauriol L. Modelling cost effectiveness of insulin glargine for the treatment of type 1 and 2 diabetes in Canada. ...
Cost-effectiveness of Insulin Glargine Versus Sitagliptin in Insulin-naïve Patients With Type 2 Diabetes Mellitus Stephen T. Brown, PhD 1 ; Daniel Grima Grima, MSc 1 ; and Luc Sauriol, MSc 2 1 Cornerstone Research Group Inc., Burlington, Ontario, Canada; and ...
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.
Cost-effectiveness of insulin glargine versus sitagliptin in insulin-naive patients with type 2 diabetes mellitus. Clin Ther. 2014;36:1576–87. CAS PubMed Google Scholar CDA. New drugs for type 2 diabetes: second-line therapy—science report. 2017. https://www.cadth.ca/sites/default/files/...
EE346 Comparative Cost and Saving Analysis of Insulin Glargine-300U/mL (Gla-300) vs Insulin Degludec 100 U/mL in the Treatment of Type 2 Diabetes Mellitus ... M Safia,Z Hachelaf,A Aissaoui,... - 《Value in Health》 被引量: 0发表: 2024年 Safety and efficacy of insulin glargine 300...
AimsThe aim of this analysis was to evaluate the cost-effectiveness of insulin degludec (IDeg) versus insulin glargine (IGlar) in adults with type 2 diabetes mellitus (T2DM) who are considered appropriate for treatment with a basal insulin analogue, using a short-term economic model.MethodsMeta...
To estimate the cost-effectiveness of insulin degludec (IDeg) versus insulin glargine U100 (IGlar U100) and new-to-market basal insulin analogues in patien... M Evans,B Chubb,J Gundgaard - 《Diabetes Therapy》 被引量: 4发表: 2017年 Modeling the Long-Term Cost-Effectiveness of IDegLira in...
Objective: To assess the cost-effectiveness of insulin icodec (IIco), the first once-weekly basal insulin, for the treatment of T2D from the Canadian public payer perspective using the Institute for Health Economics - Diabetes Cohort Model.Three T2D patient groups were analyzed: insulin nave (IN...
With one of the fastest aging populations in the world, demographic changes in Japan are a major public health concern due to the substantial burden that a
Insulin initiation in patients with type 2 diabetes mellitus: treatment guidelines, clinical evidence and patterns of use of basal vs premixed insulin analogue... A Vaag,S Lund - 《European Journal of Endocrinology》 被引量: 65发表: 2012年 Cost effectiveness of insulin glargine plus oral antidia...